JAZZ vs SIF · P/E 1988, rev $2.28B vs rev $76.6M
Jazz Pharmaceuticals PLC (JAZZ) versus SIFCO Industries Inc (SIF) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
SIFCO Industries Inc (SIF) is a aerospace & defense company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SIF revenue for 2026-06-30 was $76.6M. Net income was $4.4M. Revenue was up 51.9% from 2026-03-31 to 2026-06-30. SIF currently screens at market cap $25.0M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SIF currently screens at market cap $25.0M.
Not investment advice. Open the JAZZ and SIF stock pages for the full models.
Not investment advice.